http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)
How regulatory barriers inhibit pharmaceutical competition
Committee on Health, Education, Labor, and Pensions.
1 online resource (iii, 43 pages) : illustrations.
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families.